Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion

Twenty-two regular smokers (15+ cigarettes per day) were treated with bupropion and group therapy for 2 months. Subjects underwent positron emission tomography (PET) studies using measures of brain global and regional glucose metabolism (regional cerebral metabolic rates of glucose [rCMRglc]) with [18F]-Fluorodeoxyglucose (FDG) twice, after watching a videotape showing smoking scenes and after watching a control movie in counter-balanced order. A questionnaire of smoking urges (QSU) was filled in before and after watching both the movies. Changes in brain metabolic rates of FDG were analysed using Statistical Parametric Maps (SPM 2) in 11 smokers who abstained from smoking in comparison with 11 smokers who continued to smoke during the second month of treatment. Still-smokers had higher craving scores after watching the videotape showing smoking scenes compared with non-smokers. Second, watching the videotape showing smoking scenes compared with the control videotape in still-smokers resulted in increased metabolic rates in the striatum, thalamus and midbrain. Third, the ratings of the urge to smoke cigarettes while watching the videotape showing smoking scenes in still-smokers were associated with brain metabolic activity in the ventral striatum, anterior cingulate, orbitofrontal cortex, middle temporal lobe, hippocampus, insula, midbrain and thalamus. In conclusion, successfully treated smokers showed attenuated craving and reduced activity in the mesolimbic reward circuit.

[1]  A. Weinstein,et al.  Cognitive processing of drug-related stimuli: the role of memory and attention , 2006, Journal of psychopharmacology.

[2]  P. Jatlow,et al.  A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation , 2003, Biological Psychiatry.

[3]  J S Fowler,et al.  Regional brain metabolic activation during craving elicited by recall of previous drug experiences. , 1999, Life sciences.

[4]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[5]  J. Lorberbaum,et al.  From the Departments Of , 2022 .

[6]  R G Hoffmann,et al.  Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. , 1998, The American journal of psychiatry.

[7]  H. Damasio,et al.  Damage to the Insula Disrupts Addiction to Cigarette Smoking , 2007, Science.

[8]  Andrew J Waters,et al.  Cue-provoked craving and nicotine replacement therapy in smoking cessation. , 2004, Journal of consulting and clinical psychology.

[9]  A. Brody.  Functional brain imaging of tobacco use and dependence. , 2006, Journal of psychiatric research.

[10]  M. Jarvik,et al.  Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study , 2004, Psychiatry Research: Neuroimaging.

[11]  K. Fagerström,et al.  Neuropharmacology and potential efficacy of new treatments for tobacco dependence , 2006, Expert opinion on investigational drugs.

[12]  D. Rubin,et al.  Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. , 2002, The American journal of psychiatry.

[13]  Nicole L. Nollen,et al.  CLINICAL AND IMAGING STUDY: Enhanced cue‐elicited brain activation in African American compared with Caucasian smokers: an fMRI study , 2006, Addiction biology.

[14]  Matthew L. Ho,et al.  Brain metabolic changes during cigarette craving. , 2002, Archives of general psychiatry.

[15]  M. Jarvik,et al.  Nicotine abstinence produces content-specific stroop interference , 2005, Psychopharmacology.

[16]  M. Stitzer,et al.  Pharmacotherapy for Nicotine Dependence 1 , 2005, CA: a cancer journal for clinicians.

[17]  Bridget A. Martell,et al.  Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. , 2006, Archives of general psychiatry.

[18]  T. Turkington,et al.  Regional Brain Activity Correlates of Nicotine Dependence , 2007, Neuropsychopharmacology.

[19]  M. Ernst,et al.  Orbitofrontal cortex and human drug abuse: functional imaging. , 2000, Cerebral cortex.

[20]  J. Feighner,et al.  Bupropion: a review of its mechanism of antidepressant activity. , 1995, The Journal of clinical psychiatry.

[21]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[22]  D. Balfour.  Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence. , 2002, Current drug targets. CNS and neurological disorders.

[23]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[24]  R. Ehrman,et al.  Limbic Activation to Cigarette Smoking Cues Independent of Nicotine Withdrawal: A Perfusion fMRI Study , 2007, Neuropsychopharmacology.

[25]  Jeffrey H. Meyer,et al.  Smoking-induced ventral striatum dopamine release. , 2004, The American journal of psychiatry.

[26]  Heidi Johansen-Berg,et al.  Ventral Striatum/Nucleus Accumbens Activation to Smoking-Related Pictorial Cues in Smokers and Nonsmokers: A Functional Magnetic Resonance Imaging Study , 2005, Biological Psychiatry.

[27]  L. Ray,et al.  Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. , 2008, Addictive behaviors.

[28]  D. Schroeder,et al.  A comparison of sustained-release bupropion and placebo for smoking cessation. , 1997, The New England journal of medicine.

[29]  T. George,et al.  Current pharmacological treatments for nicotine dependence. , 2004, Trends in pharmacological sciences.

[30]  J. Kelly,et al.  Sensitization of the Mesoaccumbens Dopamine Response to Nicotine , 1998, Pharmacology Biochemistry and Behavior.

[31]  J. Greif,et al.  Motivational and Behavioral Factors Predicting Success in Cigarette Smoking-Cessation Treatment Combining Group Therapy With Bupropion , 2008 .

[32]  J. Etter.  A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. , 2005, Drug and alcohol dependence.

[33]  Edythe D London,et al.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. , 2006, Archives of general psychiatry.

[34]  A L Malizia,et al.  Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. , 2001, The American journal of psychiatry.

[35]  M. Reid,et al.  Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers , 2007, Psychopharmacology.

[36]  M. Damaj,et al.  Bupropion is a nicotinic antagonist. , 2000, The Journal of pharmacology and experimental therapeutics.

[37]  F. J. McClernon,et al.  IMAGING STUDY: Selectively reduced responses to smoking cues in amygdala following extinction‐based smoking cessation: results of a preliminary functional magnetic resonance imaging study , 2007, Addiction biology.

[38]  S. Tiffany,et al.  The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.

[39]  N. Rigotti,et al.  The effect of bupropion sustained-release on cigarette craving after smoking cessation. , 2002, Clinical therapeutics.

[40]  Mark S. Cohen,et al.  Neural Substrates of Resisting Craving During Cigarette Cue Exposure , 2007, Biological Psychiatry.